Proteomics profiling of colorectal cancer progression identifies PLOD2 as a potential therapeutic target. Issue 2 (4th December 2021) - Shao, Yingkuan; Xu, Kailun; Zheng, Xi; Zhou, Biting; Zhang, Xiuli; Wang, Lin; Sun, Yaoting; Li, Dan; Chen, Ting; Wang, Jian; Yu, Shaojun; Sun, Lifeng; et al.